Good nutrition may play a role in preserving cognitive function and reducing the risk of dementia. Research published in the American Journal of Clinical Nutrition (November 2007; Vol. 86, No. 5:1384–1391) followed more than 1,600 participants for ten years to examine the relationship between vitamin B12 status and cognitive decline.
Vitamin B12 status was assessed using holotranscobalamin and methylmalonic acid, both considered functional markers of B12 availability. Cognitive performance was evaluated on three occasions over the ten-year study period. The researchers found that higher levels of holotranscobalamin were associated with a slower rate of cognitive decline. Specifically, doubling holotranscobalamin levels was linked with an approximately 30% reduction in the rate of cognitive decline.
Mark Goodman, PhD, has suggested that a substantial number of patients diagnosed with Alzheimer’s disease may instead have dementia related to vitamin B12 deficiency. Dr. Goodman holds an accredited PhD in behavioral medicine with a specialization in clinical neuropsychology from the University of Maryland School of Medicine.
In an interview conducted by Kirk Hamilton and published in Clinical Pearls, Dr. Goodman described encountering older patients admitted with a diagnosis of Alzheimer’s disease whose frontal lobe function appeared intact. He noted that this finding is inconsistent with Alzheimer’s disease, which characteristically involves frontal lobe degeneration. Instead, these patients exhibited more generalized neuropsychological deficits consistent with a systemic or metabolic cause. Dr. Goodman observed that many of these individuals were following strict lipid-lowering diets.
Dr. Goodman has emphasized that subclinical vitamin B12 deficiency is common in the elderly, even when standard serum B12 levels fall within the normal range. Neurological changes related to B12 deficiency often occur before abnormalities appear in blood counts, such as those seen in pernicious anemia. For this reason, he stresses the importance of a thorough dietary history as part of cognitive evaluation.
According to Dr. Goodman, several factors contribute to low B12 status in older adults. Institutional and convalescent diets often contain little red meat due to cost considerations and efforts to limit dietary fat. Age-related gastric atrophy reduces stomach acid production, impairing vitamin B12 absorption. In addition, lower dietary intake may down-regulate enzymes involved in vitamin B12 metabolism. Dr. Goodman has stated that in the absence of frontal lobe degeneration, a diagnosis of Alzheimer’s disease should be reconsidered.
Regarding safety, Dr. Goodman has noted that high doses of vitamin B12 are generally well tolerated. Rare adverse effects reported in the literature include reversible diarrhea, skin rash, polycythemia, and possible peripheral vascular thrombosis, all of which are uncommon and typically resolve when supplementation is discontinued.
Vitamin B12 deficiency is relatively common in older adults. Even when serum B12 levels appear normal, symptoms such as forgetfulness, fatigue, and depression have been observed to improve when B12 status is corrected. Dr. Goodman’s central concern is that the neurological effects of vitamin B12 deficiency can be severe enough to mimic Alzheimer’s disease, leading to misdiagnosis if functional B12 deficiency is not carefully evaluated.
Educational note:
This article is for informational purposes only and is not intended as medical advice.
